Andrew Obenshain
Chief Executive Officer at BLUEBIRD BIO, INC.
Net worth: 358 397 $ as of 2024-03-30
Profile
Andrew Obenshain is currently the President, Chief Executive Officer & Director at bluebird bio, Inc. since 2021.
He is also currently serving as a Director at bluebird bio (UK) Ltd.
since 2017.
Previously, he worked as the General Manager-Finance at Shire France SAS.
Mr. Obenshain completed his undergraduate degree at Dartmouth College and holds an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.15% | 2024-03-03 | 279,998 ( 0.15% ) | 358 397 $ | 2024-03-30 |
Andrew Obenshain active positions
| Companies | Position | Start |
|---|---|---|
| BLUEBIRD BIO, INC. | Chief Executive Officer | 2021-11-03 |
bluebird bio (UK) Ltd.
 bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Director/Board Member | 2017-03-29 |
Former positions of Andrew Obenshain
| Companies | Position | End |
|---|---|---|
Shire France SAS
 Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Training of Andrew Obenshain
| Dartmouth College | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
- Stock Market
- Insiders
- Andrew Obenshain
